Gabapentin neuropathy
Pro Research Analysisby 
Searched over 200M research papers for "gabapentin neuropathy"
Gabapentin for Neuropathic Pain: Efficacy and Safety
Introduction to Gabapentin and Neuropathic Pain
Gabapentin is widely used to manage neuropathic pain, which is pain caused by nerve damage. This medication, originally developed as an antiepileptic drug, has shown promise in alleviating various types of neuropathic pain, including postherpetic neuralgia, diabetic neuropathy, and chemotherapy-induced peripheral neuropathy.
Efficacy of Gabapentin in Neuropathic Pain
Postherpetic Neuralgia and Diabetic Neuropathy
Gabapentin has been extensively studied for its efficacy in treating postherpetic neuralgia and painful diabetic neuropathy. In these conditions, gabapentin at doses of 1200 mg or more daily has been shown to provide significant pain relief. Approximately 32% of patients with postherpetic neuralgia and 38% of patients with diabetic neuropathy experienced substantial pain relief (at least 50% reduction in pain intensity) compared to 17% and 21% with placebo, respectively1 7 8. Additionally, moderate pain relief (at least 30% reduction in pain intensity) was observed in 46% of postherpetic neuralgia patients and 52% of diabetic neuropathy patients, compared to 25% and 37% with placebo, respectively1 7 8.
Chemotherapy-Induced Peripheral Neuropathy
Gabapentin has also been evaluated for chemotherapy-induced peripheral neuropathy (CIPN). Studies indicate that gabapentin can significantly reduce the severity of neuropathy symptoms in patients undergoing chemotherapy, with a notable reduction in both subjective pain scores and objective measures such as nerve conduction velocity4 9.
Comparative Studies
In a comparative study, gabapentin was found to be more effective and better tolerated than amitriptyline, a commonly used tricyclic antidepressant, for treating painful diabetic neuropathy. Patients on gabapentin reported greater reductions in pain and paresthesia scores, with fewer adverse events compared to those on amitriptyline7.
Safety and Tolerability of Gabapentin
Common Adverse Events
While gabapentin is effective in managing neuropathic pain, it is associated with several adverse events. Common side effects include dizziness (19%), somnolence (14%), peripheral edema (7%), and gait disturbance (14%)1 7 8. These side effects are generally mild and tolerable, but they can lead to discontinuation of the medication in some patients.
Serious Adverse Events
Serious adverse events are relatively rare and occur at similar rates to placebo. However, the overall incidence of any adverse event is higher in patients taking gabapentin compared to those on placebo1 7 8.
Conclusion
Gabapentin is a valuable option for managing various types of neuropathic pain, including postherpetic neuralgia, diabetic neuropathy, and CIPN. It provides significant pain relief for a substantial proportion of patients, although it is associated with a range of mild to moderate adverse events. The efficacy and safety profile of gabapentin make it a viable treatment option, but careful consideration of potential side effects is necessary to optimize patient outcomes.
Sources and full results
Most relevant research papers on this topic
Gabapentin for chronic neuropathic pain in adults.
Gabapentin at 1200 mg daily or greater provides moderate to substantial pain relief for adults with chronic neuropathic pain conditions like postherpetic neuralgia and painful diabetic neuropathy.
Systematic Review
Very Rigorous Journal
Highly CitedGabapentin Monotherapy for the Symptomatic Treatment of Painful Neuropathy: A Multicenter, Double‐blind, Placebo‐controlled Trial in Patients With Diabetes Mellitus 1
Gabapentin provides significant pain relief and improved sleep, mood, and quality of life for patients with moderate to severe diabetic neuropathy, with mild side effects.
RCTHighly CitedGabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial
Low dose gabapentin (300 mg capsules) effectively relieves pain in patients with painful diabetic neuropathy, potentially benefiting those with other neurological conditions.
RCTHighly CitedEfficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy
Gabapentin effectively relieves symptoms of chemotherapy-induced peripheral neuropathy, improving quality of life for patients.
RCTHighly CitedA gastroretentive gabapentin formulation for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial.
Once-daily G-GR is effective and well-tolerated for treating pain due to diabetic peripheral neuropathy, with low incidences of dizziness and somnolence.
RCTGabapentin for Neuropathic Pain: Systematic Review of Controlled and Uncontrolled Literature
Gabapentin is effective in treating various neuropathic conditions, but its effectiveness may be reduced at low doses and rapid dose escalation may increase central nervous system side effects.
Systematic ReviewHighly CitedGabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study.
Gabapentin is more effective and better tolerated than amitriptyline for reducing pain and paresthesia in diabetic neuropathy patients.
RCTHighly CitedGabapentin for chronic neuropathic pain and fibromyalgia in adults.
Gabapentin is an effective and safe treatment for chronic neuropathic pain and fibromyalgia in adults, with minimal adverse effects and withdrawal risk.
Systematic ReviewVery Rigorous JournalEfficacy of gabapentin for the prevention of paclitaxel induced peripheral neuropathy: A randomized placebo controlled clinical trial
Gabapentin effectively prevents intermediate and high grade neuropathies in breast cancer patients receiving paclitaxel chemotherapy, improving both objective and subjective outcomes.
RCTGabapentin for chronic neuropathic pain and fibromyalgia in adults.
Gabapentin provides moderate to substantial pain relief for chronic neuropathic pain, but has more common adverse events than other treatments.
Very Rigorous JournalHighly Cited